ArticleCurrent pharmaceutical biotechnology2024
Therapeutic Path to Triple Knockout: Investigating the Pan-inhibitory Mechanisms of AKT, CDK9, and TNKS2 by a Novel 2-phenylquinazolinone Derivative in Cancer Therapy- An
Xylia Q Peters et al.PubMed ↗Publisher ↗
No numbers read from the abstract.